Infective Hypothesis for Neurodegenerative Diseases

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 6645

Special Issue Editor


E-Mail Website
Guest Editor
Neurobiology of Alzheimer's Disease Unit, Chronic Disease Programme Instituto de Salud Carlos III, 28222 Majadahonda, Madrid, Spain
Interests: neurodegenerative diseases; aging; inflammation; diagnostic biomarker discovery; immune alterations; metabolic alterations; transgenic mouse models; saliva

Special Issue Information

Dear colleagues

Recent works speculate that a combination of genetic and environmental factors may result in neurodegenerative diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis. It is known that disease-causing mutations in several genes for Parkinson’s disease or Huntington’s disease are related to increased susceptibility to intracellular microbial infections. Recent data have demonstrated these genes may modulate innate immune responses, suggesting that immune dysregulation may play an important role in neurodegeneration. A number of observations suggest that microbial colonization, including bacterial, fungal, and viral infections, may be a risk factor for neurodegenerative diseases and might explain why the onset of these disorders appears after several decades of life.

It is my great pleasure to invite you and your teams, as experts from diverse backgrounds (medicine, immunology, clinics, genetics, molecular biology, and epidemiology), to contribute original research or review articles. We are especially interested in articles that cover studies on the identification, roles, and molecular mechanisms of microbial infection and translational approaches of clinical relevance in neurodegenerative diseases.

Prof. Eva M. Carro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Alzheimer’s disease
  • Parkinson´s disease
  • Huntington´s disease
  • neurodegeneration
  • infectious pathogens
  • antimicrobial peptides
  • neuroinflammation
  • oral infection

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 3144 KiB  
Review
The Presence of Human Herpesvirus 6 in the Brain in Health and Disease
by Gabriel Santpere, Marco Telford, Pol Andrés-Benito, Arcadi Navarro and Isidre Ferrer
Biomolecules 2020, 10(11), 1520; https://doi.org/10.3390/biom10111520 - 06 Nov 2020
Cited by 23 | Viewed by 6281
Abstract
The human herpesvirus 6 (HHV‐6) ‐A and ‐B are two dsDNA beta‐herpesviruses infecting
almost the entire worldwide population. These viruses have been implicated in multiple
neurological conditions in individuals of various ages and immunological status, including
encephalitis, epilepsy, and febrile seizures. HHV‐6s have [...] Read more.
The human herpesvirus 6 (HHV‐6) ‐A and ‐B are two dsDNA beta‐herpesviruses infecting
almost the entire worldwide population. These viruses have been implicated in multiple
neurological conditions in individuals of various ages and immunological status, including
encephalitis, epilepsy, and febrile seizures. HHV‐6s have also been suggested as playing a role in
the etiology of neurodegenerative diseases such as multiple sclerosis and Alzheimer’s disease. The
apparent robustness of these suggested associations is contingent on the accuracy of HHV‐6
detection in the nervous system. The effort of more than three decades of researching HHV‐6 in the
brain has yielded numerous observations, albeit using variable technical approaches in terms of
tissue preservation, detection techniques, sample sizes, brain regions, and comorbidities. In this
review, we aimed to summarize current knowledge about the entry routes and direct presence of
HHV‐6 in the brain parenchyma at the level of DNA, RNA, proteins, and specific cell types, in
healthy subjects and in those with neurological conditions. We also discuss recent findings related
to the presence of HHV‐6 in the brains of patients with Alzheimer’s disease in light of available
evidence. Full article
(This article belongs to the Special Issue Infective Hypothesis for Neurodegenerative Diseases)
Show Figures

Figure 1

Back to TopTop